Innovative device detects prostate cancer, kidney disease on the spot
When you flush the toilet, you may be discarding microscopic warning signs about your health.
But a cunningly simple new device can stop that vital information from “going to waste.”
Brigham Young University chemist Adam Woolley and his students made a device that can detect markers of kidney disease and prostate cancer in a few minutes. All you have to do is drop a sample into a tiny tube and see how far it goes.
That’s because the tube is lined with DNA sequences that will latch onto disease markers and nothing else. Urine from someone with a clean bill of health would flow freely through the tube (the farther, the better). But even at ultra-low concentrations, the DNA grabs enough markers to slow the flow and signal the presence of disease.
“In a disease state, this particular marker is equal to about one billionth of a percent of the content of urine.” Woolley said. “We can detect close to those levels. If we can get below that, it would give us better sensitivity for somebody at an early stage of the disease.”
Grad students Debolina Chatterjee and Danielle Mansfield co-authored the study for the journal Analytical Methods using synthetic urine samples. The next step is to do human trials with this “lab on a chip.”
The method holds several advantages over current tests for prostate cancer: No blood draws, instant results and potentially higher accuracy.
The Latest on: Disease diagnostics
via Google News
The Latest on: Disease diagnostics
- Companion Diagnostics Services Market, 2020-2030on March 24, 2020 at 8:31 am
INTRODUCTION Personalized medicine has brought about a paradigm shift within the healthcare sector. However, therapies tailored to specific disease-related molecular signatures require appropriate ...
- FDA authorizes hand-held COVID-19 diagnostic teston March 24, 2020 at 7:20 am
The company is also working on a larger respiratory panel that will detect additional pathogens in order to rule out and rule in diseases with similar symptoms to COVID-19. In addition, bioMerieux ...
- Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Forecast to Grow by US$1.2 Billion, Driven by a CAGR of 7%on March 24, 2020 at 7:00 am
/PRNewswire/ -- The "Cardiovascular Disease Monitoring and Diagnostic Devices - Market Analysis, Trends, and Forecasts" report has been added to ...
- Crohn's Disease Diagnostic and Therapeutic Market Future Investment and Forecast 2029 | AbbVie and Celgene Corporationon March 24, 2020 at 6:29 am
Mar 24, 2020 (WiredRelease via COMTEX) -- “Market.us, Recently Published Report on “Crohn’s Disease Diagnostic and Therapeutic Market Moving Towards 2020 ...
- One-hour coronavirus triage test developed by SQI Diagnostics to receive funding from University Health Networkon March 24, 2020 at 6:15 am
/PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary ...
- The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnosticson March 24, 2020 at 5:44 am
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics ...
- A Microbiome Search Engine for Disease Diagnosticson March 24, 2020 at 5:00 am
This search-based strategy shows promise as an essential first step in microbiome big-data-based diagnosis.” Traditional models compare samples from healthy subjects to those from people known to have ...
- Applied DNA +16% premarket after filing provisional patent for COVID-19 diagnostic assayon March 24, 2020 at 4:22 am
Applied DNA Sciences (NASDAQ:APDN) has filed a provisional patent application with the USPTO for its diagnostic assay under development for SARS-CoV-2, the virus that causes the disease COVID-19.The ...
- OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Diagnostic Microbiology & Infectious Disease Journalon March 23, 2020 at 5:52 pm
GAITHERSBURG, Md., March 23, 2020 -- OpGen, Inc. (Nasdaq: OPGN) announced today that its Acuitas Lighthouse® was used in a study conducted by the Mayo Clinic to predict.
- The 'RHONY' Cast Reacts To Ramona Singer's Lyme Disease Diagnosison March 23, 2020 at 5:27 pm
Ramona Singer has received support from her Real Housewives of New York City co-stars after coming forward with her Lyme disease diagnosis earlier this month on her Instagram Stories, weeks before she ...
via Bing News